Literature DB >> 16496101

[Medical emergencies following dermatological injections and infusions].

D Dill-Müller1.   

Abstract

Emergency situations following appropriately administered injections and infusions are an uncommon dermatologic problem. Embolia cutis medicamentosa is an uncommon complication following intramuscular injection which leads to infarct-like cutaneous necrosis. It may develop after gluteal injection of corticosteroids, anti-inflammatory agents and antibiotics and has rarely been described following venous sclerotherapy with polidocanol. Hoigné syndrome is a pseudoanaphylactic or pseudoallergic reaction following intramuscular injection of procaine penicillin, with neuropsychiatric problems developing immediately after the injection. Subacute forms following intramuscular or oral administration of structurally-related antibiotics. The intraoperative use of patent blue dye has a 1-2% risk of allergic reactions. The patient must be monitored carefully following injection for the onset the life-threatening immediate reaction. Extravasation of cytostatic agents is a critical iatrogenic problem in oncology with an incidence of up to 6.5%. Every oncologic department should have an understanding of necrotic risk of the various agents and an emergency kit with instructions for immediate steps, also including agent-specific antidotes as available.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16496101     DOI: 10.1007/s00105-006-1107-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  31 in total

Review 1.  [Hoigne syndrome. Case report and current literature review].

Authors:  W Schreiber; J C Krieg
Journal:  Nervenarzt       Date:  2001-07       Impact factor: 1.214

2.  Flow-assisted diagnosis of anaphylaxis to patent blue.

Authors:  D G Ebo; R D Wets; T K Spiessens; C H Bridts; W J Stevens
Journal:  Allergy       Date:  2005-05       Impact factor: 13.146

3.  Severe anaphylactic shock with methylene blue instillation.

Authors:  Pascale Dewachter; Claudie Mouton-Faivre; Philippe Tréchot; Jean-Claude Lleu; Paul Michel Mertes
Journal:  Anesth Analg       Date:  2005-07       Impact factor: 5.108

4.  Local skin necroses after intramuscular injection -Experimental animal studies-.

Authors:  R Brachtel; T Meinertz
Journal:  Arch Dermatol Res       Date:  1977-05-27       Impact factor: 3.017

5.  [Atypical zosteriform segmental embolia cutis medicamentosa].

Authors:  L D Köhler; W I Worret; H Hofmann
Journal:  Hautarzt       Date:  1997-07       Impact factor: 0.751

6.  [Early and late treatment of iatrogenic injection damage].

Authors:  D von Heimburg; N Pallua
Journal:  Chirurg       Date:  1998-12       Impact factor: 0.955

7.  [Intraoperative detection of sentinel lymph nodes in cutaneous malignant melanoma -- blue dye alone versus blue dye plus gamma detection].

Authors:  Lutz Kretschmer; Sabine Peeters; Iris Beckmann; Kai-Martin Thoms; Christina Mitteldorf; Steffen Emmert; Carsten-Oliver Sahlmann; Hans Peter Bertsch; Christine Neumann; Johannes Meller
Journal:  J Dtsch Dermatol Ges       Date:  2005-08       Impact factor: 5.584

8.  The use of hyaluronidase in the treatment of intravenous extravasation injuries.

Authors:  W V Raszka; T K Kueser; F R Smith; J W Bass
Journal:  J Perinatol       Date:  1990-06       Impact factor: 2.521

9.  Treatment of extravasation of both doxorubicin and vincristine administration in a Y-site infusion.

Authors:  D Comas; J Mateu
Journal:  Ann Pharmacother       Date:  1996-03       Impact factor: 3.154

10.  [Diffuse dermal angiomatosis].

Authors:  H Kutzner; L Requena; T Mentzel; B Pfau
Journal:  Hautarzt       Date:  2002-12       Impact factor: 0.751

View more
  1 in total

1.  [Patent blue V : inert dye or potent allergen].

Authors:  V Rogler; C Röhm; J Reutershan
Journal:  Anaesthesist       Date:  2010-05       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.